S&P 500   5,253.45 (+0.09%)
DOW   39,787.01 (+0.07%)
QQQ   444.17 (-0.15%)
AAPL   171.46 (-1.07%)
MSFT   420.29 (-0.27%)
META   488.07 (-1.17%)
GOOGL   150.83 (-0.03%)
AMZN   180.47 (+0.36%)
TSLA   176.87 (-1.65%)
NVDA   905.13 (+0.29%)
NIO   4.54 (-2.78%)
AMD   180.63 (+0.58%)
BABA   72.50 (+1.27%)
T   17.68 (+0.74%)
F   13.24 (+1.38%)
MU   117.73 (-1.18%)
CGC   9.12 (-4.50%)
GE   174.95 (-2.87%)
DIS   122.77 (+1.48%)
AMC   3.69 (-14.98%)
PFE   28.05 (+0.97%)
PYPL   67.23 (+0.99%)
XOM   116.12 (+1.00%)
S&P 500   5,253.45 (+0.09%)
DOW   39,787.01 (+0.07%)
QQQ   444.17 (-0.15%)
AAPL   171.46 (-1.07%)
MSFT   420.29 (-0.27%)
META   488.07 (-1.17%)
GOOGL   150.83 (-0.03%)
AMZN   180.47 (+0.36%)
TSLA   176.87 (-1.65%)
NVDA   905.13 (+0.29%)
NIO   4.54 (-2.78%)
AMD   180.63 (+0.58%)
BABA   72.50 (+1.27%)
T   17.68 (+0.74%)
F   13.24 (+1.38%)
MU   117.73 (-1.18%)
CGC   9.12 (-4.50%)
GE   174.95 (-2.87%)
DIS   122.77 (+1.48%)
AMC   3.69 (-14.98%)
PFE   28.05 (+0.97%)
PYPL   67.23 (+0.99%)
XOM   116.12 (+1.00%)
S&P 500   5,253.45 (+0.09%)
DOW   39,787.01 (+0.07%)
QQQ   444.17 (-0.15%)
AAPL   171.46 (-1.07%)
MSFT   420.29 (-0.27%)
META   488.07 (-1.17%)
GOOGL   150.83 (-0.03%)
AMZN   180.47 (+0.36%)
TSLA   176.87 (-1.65%)
NVDA   905.13 (+0.29%)
NIO   4.54 (-2.78%)
AMD   180.63 (+0.58%)
BABA   72.50 (+1.27%)
T   17.68 (+0.74%)
F   13.24 (+1.38%)
MU   117.73 (-1.18%)
CGC   9.12 (-4.50%)
GE   174.95 (-2.87%)
DIS   122.77 (+1.48%)
AMC   3.69 (-14.98%)
PFE   28.05 (+0.97%)
PYPL   67.23 (+0.99%)
XOM   116.12 (+1.00%)
S&P 500   5,253.45 (+0.09%)
DOW   39,787.01 (+0.07%)
QQQ   444.17 (-0.15%)
AAPL   171.46 (-1.07%)
MSFT   420.29 (-0.27%)
META   488.07 (-1.17%)
GOOGL   150.83 (-0.03%)
AMZN   180.47 (+0.36%)
TSLA   176.87 (-1.65%)
NVDA   905.13 (+0.29%)
NIO   4.54 (-2.78%)
AMD   180.63 (+0.58%)
BABA   72.50 (+1.27%)
T   17.68 (+0.74%)
F   13.24 (+1.38%)
MU   117.73 (-1.18%)
CGC   9.12 (-4.50%)
GE   174.95 (-2.87%)
DIS   122.77 (+1.48%)
AMC   3.69 (-14.98%)
PFE   28.05 (+0.97%)
PYPL   67.23 (+0.99%)
XOM   116.12 (+1.00%)
NASDAQ:AMTI

Applied Molecular Transport (AMTI) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.26
$0.26
50-Day Range
$0.16
$0.31
52-Week Range
$0.13
$0.84
Volume
N/A
Average Volume
470,969 shs
Market Capitalization
$10.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
AMTI stock logo

About Applied Molecular Transport Stock (NASDAQ:AMTI)

Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trials to treat patients with chronic pouchitis, as well as is in Phase II development to treat patients with rheumatoid arthritis. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral and respiratory biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California. As of December 27, 2023, Applied Molecular Transport Inc. operates as a subsidiary of Cyclo Therapeutics, Inc.

AMTI Stock News Headlines

Founders Fund V, LP's Net Worth
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Applied Molecular Transport (NASDAQ: AMTI)
AMTI Applied Molecular Transport Inc.
3 Analysts Have This to Say About Applied Molecular
Applied Molecular To Explore Strategic Alternatives
See More Headlines
Receive AMTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Applied Molecular Transport and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/10/2021
Today
3/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:AMTI
Fax
N/A
Employees
13
Year Founded
N/A

Profitability

Net Income
$-126,320,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$1.56 per share

Miscellaneous

Free Float
34,764,000
Market Cap
$10.87 million
Optionable
Not Optionable
Beta
2.28
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

AMTI Stock Analysis - Frequently Asked Questions

How were Applied Molecular Transport's earnings last quarter?

Applied Molecular Transport Inc. (NASDAQ:AMTI) released its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.68) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.62) by $0.06.

What other stocks do shareholders of Applied Molecular Transport own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Applied Molecular Transport investors own include CVS Health (CVS), Home Depot (HD), Procter & Gamble (PG), RTX (RTX), Thermo Fisher Scientific (TMO), Alibaba Group (BABA), Cisco Systems (CSCO), Johnson & Johnson (JNJ) and Resideo Technologies (REZI).

When did Applied Molecular Transport IPO?

Applied Molecular Transport (AMTI) raised $130 million in an initial public offering (IPO) on Friday, June 5th 2020. The company issued 10,000,000 shares at $12.00-$14.00 per share. BofA Securities, Jefferies and SVB Leerink served as the underwriters for the IPO.

Who are Applied Molecular Transport's major shareholders?

Applied Molecular Transport's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Aaron Vandevender, Bittoo Kanwar, Brandon Hants, David Lamond, Douglas A Rich, Elizabeth Bhatt, Epiq Capital Group, Llc, Helen Susan Kim, Randall PhD Mrsny, Shawn Cross and Tahir PhD Mahmood.
View institutional ownership trends
.

This page (NASDAQ:AMTI) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners